Correlation Between Fennec Pharmaceuticals and Acurx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Acurx Pharmaceuticals.

Diversification Opportunities for Fennec Pharmaceuticals and Acurx Pharmaceuticals

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fennec and Acurx is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Acurx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and Acurx Pharmaceuticals

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 0.66 times more return on investment than Acurx Pharmaceuticals. However, Fennec Pharmaceuticals is 1.52 times less risky than Acurx Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.07 per unit of risk. If you would invest  1,016  in Fennec Pharmaceuticals on November 5, 2024 and sell it today you would lose (366.00) from holding Fennec Pharmaceuticals or give up 36.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fennec Pharmaceuticals  vs.  Acurx Pharmaceuticals LLC

 Performance 
       Timeline  
Fennec Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.
Acurx Pharmaceuticals LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Fennec Pharmaceuticals and Acurx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fennec Pharmaceuticals and Acurx Pharmaceuticals

The main advantage of trading using opposite Fennec Pharmaceuticals and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.
The idea behind Fennec Pharmaceuticals and Acurx Pharmaceuticals LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon